EpiVario Inc.
Pharmaceutical company · Philadelphia, Pennsylvania, United States
EpiVario Inc. is a pharmaceutical company headquartered in Philadelphia, Pennsylvania, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $830,549 in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $125,000 sold in a notice filed in 2024.
EpiVario at a glance
What does EpiVario do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $830,549 in total (2022 to 2024). NIH funding came from the National Institute on Drug Abuse, National Institute on Alcohol Abuse and Alcoholism.
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $125,000 sold (2024).
Frequently asked questions about EpiVario
Where is EpiVario headquartered?
EpiVario Inc. is headquartered in Philadelphia, Pennsylvania, United States.
What does EpiVario do?
EpiVario Inc. is a pharmaceutical company.
When was EpiVario founded?
The earliest incorporation on record for EpiVario Inc. is in 2017, according to public company registers.
Similar companies
- Context Therapeutics Inc.Philadelphia, Pennsylvania, United States
- Lannett Co IncPhiladelphia, Pennsylvania, United States
- Carisma Therapeutics Inc.Philadelphia, Pennsylvania, United States
- Avid Radiopharmaceuticals, Inc.Philadelphia, Pennsylvania, United States
- Verismo Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Aro Biotherapeutics CoPhiladelphia, Pennsylvania, United States
- Alveus Therapeutics, Inc.Philadelphia, Pennsylvania, United States
- Mebias Discovery, Inc.Philadelphia, Pennsylvania, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences